Neovasc Inc. T.NVC

Primary Symbol: NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > Delisting

<< Previous

Bullboard Posts

Next >>

Comment by Barewoodon Jul 12, 2018 12:08am

274 Views

Post# 28304067

RE:RE:RE:RE:Delisting

Stonehouse97 wrote: They are deluding themselves if they think it will hold at $1 after RS.

Stonehouse, Neovasc is not effecting a R/S yet if at all. I think once it has NASDAQ approval, shareholder confidence will be back in full swing. Getting its clinicals on the way in the U.S., which by the way has already been given the green light, will move this thing big time.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market